Analysis of development dynamics of the program «Affordable medicines» in Ukraine and Lviv region

Self Cite

Improving access and affordability for patients of essential drugs in the treatment of cardiovascular diseases is a priority because mortality and a morbidity rates are high in Ukraine. In April 2017, the government launched the reimbursement program «Affordable medicines», which included drugs to treat cardiovascular disease. The aim of the study was a retrospective analysis of released prescriptions on the example of the pharmacy № 1 in Vynohradiv, Transcarpathian region, which serves patients from the city and Vynohradiv district, which allowed us to analyze and compare the structure of the appointments of primary care physicians and to identify the main INN, stocks of which should be a priority in pharmacies for the treatment of cardiovascular diseases. The objects of study were the records of the pharmacies about drugs released in the program for 24 months, the Orders of the Ministry of Health of Ukraine, the CMU Decisions, the Drug Registry for cardiovascular diseases, the cost for reimbursement in the program «Affordable Medicines» as well. Frequency analysis methods, ATC/DDD methodology, as well as methods of comparative, logical and content analysis were used. Data for the selected period were analyzed using frequency analysis methods and ATC/DDD method, and it was found that enalapril, spironolactone and clopidogrel were in the lead. It was found that the majority of patients in 2017 chose free drugs (more than 80%), and in 2018–2019 this rate was only 60%. According to prescriptions, about 92% are patients from Vynohradiv district, which confirms the improvement of access to drugs in the program «Affordable Medicines» for the rural population. The results were verified by comparing the released e-prescriptions for cardiovascular diseases in the city and district and found that the structure of prescriptions for cardiovascular diseases on e-prescriptions from April 2019 to April 2020 remains stable and the main share is 4 INN: clopidogrel, enalapril, amlodipine and bisoprolol. It is determined that in order for the «Affordable Medicines» program, the provision and convenience of patients, the pharmacies need to have an expanded list of trade names and a sufficient supply of enalapril, spironolactone, clopidogrel and bisoprolol.

unclassified

Retrospective analysis of prescriptions for the treatment of cardiovascular diseases in the program «Affordable medicines» on the example of a pharmacy

Huz

Zaliska

Maksymovych

2020

Self Cite

Analysis of the tendencies and dynamics of electronic receipt prescribing for antibiotics and their electronic dispensing in Ukraine and Lviv region

Блавацька,

Яцкова,

Сосновська

2023

Uncontrolled use of antibiotics (antibacterial, antimicrobial agents) leads to the growth of antibiotic resistance, which has become a global health problem. E-prescribing should increase the population's access to medical and pharmaceutical care. The purpose of the study: to establish the general trends of electronic prescribing of antibacterial drugs in Ukraine since its introduction in August 2022 and the impact of receipt e-prescribing on the controllability of antibiotic use, as well as to analyze the dynamics of the number of prescribed and dispensed electronic prescriptions for antibacterial drugs. We used the following research methods: informative, comparative and retrospective analysis of the dynamics of e-prescriptions for antibiotics. For this purpose, we used the e-data dashboards of the National Health Service of Ukraine (NHSU) and the data of the ENT KP «Pharmacy No.1» in Lviv for the period 08. 2022–05. 2023. In general, Lviv region is consistently in the top three, five or ten regions according to certain indicators. It was established that Lviv region is on the third place in Ukraine in terms of the number of issued e-prescriptions for antibiotics, on the first place in terms of the number of dispensed specified prescriptions, but in terms of the ratio of the number of issued e-prescriptions to those issued, Lviv region is in tenth place. The e-data of the National Health Service of Ukraine shows the nomenclature and number of electronic prescriptions of antibacterial drugs, the number of e-prescriptions that have been released, which are registered in the e-healthcare system. However, during the period of martial law, data on antibacterial drugs dispensed according to paper prescriptions or information certificates, equivalent to them, are not recorded. Thus, the e-data reflect the actual consumption of only those antibiotics that are recorded through the redemption of e-prescriptions, i.e. cover only one prescription segment. It is shown that although e-prescribing increases the control over the prescription of antibiotics, however, in force majeure circumstances of wartime, e-dispensing does not reflect the real picture of antibiotic consumption in general, but only one segment that is recorded in the e-system of health care. However, it is impractical to introduce an exclusively electronic prescription for antibiotics under martial law, as this carries the risk of limiting access to medical care. The use of the e-system allows to establish control over the quantitative indicators and assortment composition of antibiotics prescribed by doctors, which is definitely a necessary stage for improving the rational use of antibacterial drugs and combating antibiotic resistance.

Analysis of the dynamics of the nomenclature of medicines for the treatment of mental and behavioral disorders in the government program «Affordable Medicines»

Костюк,

Косяченко

2024

The number of patients with mental and behavioral disorders is growing rapidly in many countries around the world. Ukraine is not exception. The consequences of a full-scale war will cause severe mental trauma, as every 10th resident of our country now experiences depression, anxiety, and psychosomatic disorders that can last up to 10 years. All of this demonstrate the incredible relevance of comprehensive research to counteract the rapid increase in the incidence of mental and behavioral disorders, to find tools for effective treatment of this group of nosologies, and to find ways to improve the quality of life of patients. The aim of the study was to analyze the dynamics of the nomenclature of medicines for the treatment of mental and behavioral disorders in the Government Program «Affordable Medicines» for 2021–2024. To achieve this goal, we applied content analysis of regulatory legal acts using market research, as well as methods of comparative, statistical and economic analysis, as well as systematization and generalization. The results of the content analysis of all editions of the List of Medicinal Products Subject to Reimbursement under the State Guarantees for Medical Care of the Population revealed a stabilization of the number of international generic and brand names presented in the Government Program «Affordable Medicines» (9 and 65 respectively). However, given the martial law situation in Ukraine, the nomenclature of this group of drugs needs to be expanded. It was found that the range of medicinal products under study is dominated by domestically manufactured drugs, their segment is 54.5%, formed by 11 Ukrainian pharmaceutical companies. The foreign share is represented by 9 manufacturing countries, the most represented among which is India (16.9%). The number of medicinal products with full and partial reimbursement was analyzed and it was found that each of the international generic names under study has at least 1 product subject to full reimbursement. However, it is necessary to increase the number of medicines that are dispensed to patients free of charge for each international generic name, as a significant number of Ukrainians have mental and behavioral disorders and need greater economic accessibility to this particular group of drugs under martial law.